Profile: Stem Cell Therapeutics Corp. is a biotechnology company that focuses on the development of drug based therapies to treat central nervous system diseases. Our products include NTx™-265 for the treatment of acute stroke & secondary program, NTx™-428 for traumatic brain injury and NTx™-488 for multiple sclerosis. Our NTx™-265 treatment works by stimulating the growth & differentiation of new neurons to replace the brain cells that are lost or damaged by the stroke.